Stimulation of c-Rel transcriptional activity by PKA catalytic subunit β

Journal of Molecular Medicine

Volumn 82, Issue 9, 2004, Pages 621-628

  Yu, Shih Hung ^a   Chiang, Wei Chung ^a   Shih, Hsiu Ming ^b   Wu, Kou Juey ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

c MYC; c Rel; Nuclear factor kB; Protein kinase A catalytic subunit ; Transcription

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSFORMATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEEDBACK SYSTEM; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE C MYC; PROTEIN PHOSPHORYLATION; TARGET CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CONSENSUS SEQUENCE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; E1A-ASSOCIATED P300 PROTEIN; GENES, MYC; GENES, REL; GENES, REPORTER; IMMUNOPRECIPITATION; ISOENZYMES; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS C-REL; RATS; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 4744346709     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0559-7     Document Type: Article

References (39)

1. Ghosh S, May MJ, Kopp EB (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260
2. Gerondakis S, Grumont R, Rouke I, Grossman M (1998) The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr Opin Immunol 10:353-359
3. Mercurio F, Manning AM (1999) Multiple signals converging on NF-κB. Curr Opin Cell Biol 11:226-232
4. Mayo MW, Baldwin AS (2000) The transcription factor NF-κB: control of oncogenesis and cancer gene therapy. Biochim Biophys Acta 1470:M55-M62
5. Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947
6. Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC (2002) c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 14:905-916
7. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19:5785-5799
8. Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD (2002) The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway. Oncogene 21:8759-8768
9. Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ, Siebert R (2002) Recurrent involvement of the Rel and Bc111A loci in classical Hodgkin lymphomas. Blood 99:1474-1477
10. Ni H, Ergin M, Huang Q, Qin JZ, Amin HM, Martinez RL, Saeed S, Barton K, Alkan S (2001) Analysis of expression of nuclear factor kappa B (NF-κB) in multiple myeloma: down-regulation of NF-kB induces apoptosis. Br J Haematol 115:279-286
11. Gilmore T, Gapuzan ME, Kalaitzidis D, Starczynowski D (2002) Rel/NF-κB/I-κB signal transduction in the generation and treatment of human cancer. Cancer Lett 181:1-9
12. Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME (2001) Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20:7098-7103
13. Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Gollag E, Seldin DC, Cardiff RD, Sonenshein GE (2003) Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 23:5738-5754
14. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ (2002) The function of multiple I-κB: NF-κB complexes induce the resistance of cancer cells to taxol-induced apoptosis. Oncogene 21:6510-6519
15. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-424
16. Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-κB p65 by PKA stimuates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671
17. Wu KJ, Mattioli M, Morse HC III, Dalla-Favera R (2002) c-MYC activates protein kinase A (PKA) by directional transcriptional activation of the PKA catalytic subunit beta (PKA-Cβ) gene. Oncogene 21:7872-7882
18. Daniel PB, Walker WH, Habener JF (1998) Cyclic AMP signaling and gene regulation. Annu Rev Nutr 18:353-383
19. Taylor SS, Buechler JA, Yonemoto W (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59:971-1005
20. Skalhegg BS, Tasken K (2000) Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 5:D678-D693
21. Montminy M (1997) Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66:807-822
22. Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H, Kolch W (2002) Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol 22:3237-3246
23. Gu W, Cechova K, Tassi V, Dalla-Favera R (1993) Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci USA 90:2935-2939
24. Wu KJ, Polack A, Dalla-Favera R (1999) Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676-679
25. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21:220-224
26. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
27. Loeb DM, Tsao H, Cobb MH, Greene LA (1992) NGF and other growth factors induce an association between ERK1 and the NGF receptor, gp140 prototrk. Neuron 9:1053-1065
28. Martin AG, Fresno M (2000) Tumor necrosis factor-α activation of NF-κB requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J Biol Chem 275:24383-24391
29. Naumann M, Scheidereit C (1994) Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J 13:4597-4607
30. Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, Delecluse HJ, Rottenberger C, Bornkamm GW, Hammerschmidt W (1995) B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14:88-96
31. Jiang J, Struhl G (1995) Protein kinase A and hedgehog signaling in Drosophila limb development. Cell 80:563-572
32. Chen C, Agnes F, Gelinas C (1999) Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic and transforming activities of the v-Rel oncoprotein. Mol Cell Biol 19:307-316
33. Rayet B, Fan Y, Gelinas C (2003) Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-κB-regulated cell death inhibitors important for v-Rel transforming activity. Mol Cell Biol 23:1520-1533
34. Chen C, Edelstein LC, Gelinas C (2000) The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL. Mol Cell Biol 20:2687-2695
35. Sun SC, Maggirwar SB, Harhaj EW, Uhlik M (1999) Binding of c-Rel to STAT5 target sequences in HTLV-1-transformed T cells. Oncogene 18:1401-1409
36. Petrenko O, Ischenko I, Enrietto PJ (1997) Characterization of changes in gene expression associated with malignant transformation by the NF-κB family member, v-Rel. Oncogene 15:1671-1680
37. Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE (1995) Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 181:1169-1177
38. Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM (2000) NF-κB activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J Biol Chem 275:32338-32446
39. Ji L, Arcinas M, Boxer LM (1994) NF-κB sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma. Mol Cell Biol 14:7967-7974